Existing investor McKesson Ventures co-led the $22.5m round, which will enable IVX Health to open additional infusion and injection therapies centres.

US-based infusion centre operator IVX Health received $22.5m on Monday in a funding round co-led by McKesson Ventures, the investment arm of medical product distributor McKesson. Venture capital firm Health Velocity Capital co-led the round, which also featured fellow VC firms Nueterra Capital and CrimsoNox Capital. IVX Health operates centres that provide infusion and injection…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.